Linsitinib (OSI-906) Mechanism of Action: IGF-1R Inhibition in Orbital Fibroblast Research

Linsitinib (OSI-906) MOA:Targeting IGF-1R/PI3K for Thyroid Eye Disease

🎯 check Linsitinib (OSI-906) product page

Linsitinib (OSI-906) is a potent small-molecule dual IGF-1R/IR kinase inhibitor. It blocks PI3K/Akt and MAPK/ERK signaling by suppressing receptor phosphorylation, effectively inhibiting tumor cell proliferation, migration, and inducing apoptosis.

Primary Applications and Mechanism of Action